AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.
This webinar is broadcast in association with the British Journal of Cardiology; our media partner is GPnotebook, who have had no input into the content of the activity.
Presenters:
Dr Paul Foley
Prof Terry McCormack
A review of the most significant changes in the 2024 guideline updates, and what they mean for everyday UK practice: